Restless Legs Syndrome in Patients With Chronic Kidney Disease

被引:67
作者
Novak, Marta [1 ,2 ]
Winkelman, John W. [3 ]
Unruh, Mark [4 ]
机构
[1] Univ Toronto, Dept Psychiat, Univ Hlth Network, Toronto, ON, Canada
[2] Semmelweis Univ, Inst Behav Sci, H-1085 Budapest, Hungary
[3] Massachusetts Gen Hosp, Dept Psychiat, Sleep Disorders Clin Res Program, Boston, MA 02114 USA
[4] Univ New Mexico, Sch Med, Div Nephrol, Albuquerque, NM 87131 USA
关键词
Chronic kidney disease; dialysis; kidney transplantation; quality of life; restless legs syndrome; sleep; PLACEBO-CONTROLLED TRIAL; QUALITY-OF-LIFE; PERIODIC LIMB MOVEMENTS; DOUBLE-BLIND; HEMODIALYSIS-PATIENTS; GABAPENTIN ENACARBIL; SLEEP DISORDERS; CLINICAL CHARACTERISTICS; CARDIOVASCULAR RISK; DIALYSIS PATIENTS;
D O I
10.1016/j.semnephrol.2015.06.006
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Symptoms of restless legs syndrome (RLS) are common in patients with chronic kidney disease (CKD) on dialysis; symptoms of RLS are estimated to affect up to 25% of patients on dialysis when the international RLS diagnostic criteria are applied. RLS is a neurologic disorder with a circadian rhythmicity characterized by an overwhelming urge to move the legs during rest, which can be relieved temporarily by movement. RLS has been associated with an increase in sleep disturbance, higher cardiovascular morbidity, decreased quality of life, and an increased risk of death in patients with CKD. Although the exact pathophysiology of RLS is unknown, it is thought to involve an imbalance in iron metabolism and dopamine neurotransmission in the brain. The symptoms of moderate to severe RLS can be treated with several pharmacologic agents; however, data specific to patients on dialysis with RLS are lacking. The purpose of this article is to examine the relationship between, and complications of, RLS and CKD both in dialysis and nondialysis patients, and discuss the treatment options for patients on dialysis with RLS. (C) 2015 Published by Elsevier Inc.
引用
收藏
页码:347 / 358
页数:12
相关论文
共 99 条
  • [1] A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome
    Allen, Richard
    Chen, Crystal
    Soaita, Adina
    Wohlberg, Christopher
    Knapp, Lloyd
    Peterson, Barry T.
    Garcia-Borreguero, Diego
    Miceli, Jeffrey
    [J]. SLEEP MEDICINE, 2010, 11 (06) : 512 - 519
  • [2] Controversies and challenges in defining the etiology and pathophysiology of restless legs syndrome
    Allen, Richard P.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2007, 120 (01) : S13 - S21
  • [3] Prevalence and Disease Burden of Primary Restless Legs Syndrome: Results of a General Population Survey in the United States
    Allen, Richard P.
    Bharmal, Murtuza
    Calloway, Michael
    [J]. MOVEMENT DISORDERS, 2011, 26 (01) : 114 - 120
  • [4] Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology - A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health
    Allen, RP
    Picchietti, D
    Hening, WA
    Trenkwalder, C
    Walters, AS
    Montplaisi, J
    [J]. SLEEP MEDICINE, 2003, 4 (02) : 101 - 119
  • [5] Restless legs syndrome prevalence and impact - REST general population study
    Allen, RP
    Walters, AS
    Montplaisir, J
    Hening, W
    Myers, A
    Bell, TJ
    Ferini-Strambi, L
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (11) : 1286 - 1292
  • [6] [Anonymous], J AM SOC NEPHROL S
  • [7] [Anonymous], 2012 REV IRLSSG DIAG
  • [8] [Anonymous], HORIZANT GAB EN EXT
  • [9] [Anonymous], MIRAPEX PRAM DIH TAB
  • [10] [Anonymous], REQUIP ROP TABL PRES